Wednesday, July 4, 2012
Serum Institute of India Ltd. acquires Bilthoven Biologicals of Netherlands
Serum Institute of India Ltd. has acquired Bilthoven Biologicals of Netherlands. Through the acquisition, the Serum Institute will get access to technology and expertise for making the Injectable Polio Vaccine (Salk), a unique capability and expertise that is currently possessed by a mere three other vaccine manufacturing plants globally.  more....

Sunday, June 3, 2012      PuneMirror
Meeting minutes with Bill Gates
Charity has different faces, and the Microsoft founder wears one defined by humility, found the Poonawallas as they showed him around their vaccine manufacturing facility.  more....

Friday, June 1, 2012      The Indian Express
Bill Gates visits Serum Institute, meets vaccine hero Poonawalla
Bill Gates on Thursday visited the Serum Institute of India in Pune, met its CMD Dr. Cyrus Poonawalla whom he referred to as one of the seven vaccine heroes, and evinced interest in several products it is developing.  more....

Wednesday, November 2, 2011      Forbes.com
Bill Gates lists Dr. Cyrus Poonawalla as one of seven Most Influential Vaccine Heroes
His Serum Institute, says Gates, “makes more vaccines than anybody,” including one for meningitis that sells for a mere 50 cents a dose. These pioneers in breakthrough research (and, in one case, manufacturing) are “fascinating, mythic guys,” says Gates.  more....

Friday, August 5, 2011      Serum Institute of India Ltd., Pune
Serum & Merck Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine
Serum Institute of India Ltd. and Merck have entered into an agreement to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries of the world.  more....

Monday, July 11, 2011      Press Information Bureau, Government of India
WHO lauds Serum Institute's efforts at BRICS meeting  in China
WHO Director-General Dr. Margaret Chan singled out India's effort when she stated that when African countries wanted a meningococcal vaccine at a cost of not more than 50 cents, it was the Serum Institute of India which came forward and did the job. “All the major manufacturers of the world were approached by WHO but could not meet the cost criteria, which was critical for the African countries. The supply of this vaccine by India has saved hundreds and thousand of lives in low & middle income African countries, where a person contracting meningitis often means 4-5 months of a household's income” she said.  more....

Tuesday, June 14, 2011      Times of India
City's Serum Institute plays vital role in saving lives
Bill Gates & British Prime Minister David Cameron praise Dr. Cyrus Poonawalla & Serum Institute for cutting vaccine prices. Serum offered GAVI the pentavalent vaccine at $1.75 per dose. The vaccine was purchased by GAVI a couple of years ago at more than $3 per dose.  more....

Tuesday, June 14, 2011      Sakal Times
Serum's vaccine will be world's most affordable
Dr. Poonawalla makes far-reaching pledge to Global Alliance for Vaccines and Immunisation (GAVI) in London. Serum Institute has made a commitment to cut the price of its pentavalent vaccine by 60 %  - the lowest possible cost in the world.  more....

Tuesday, June 14, 2011      DNA
Pharma giants urged to lower vaccine prices
Serum Institute of India Ltd (SII), at an international meet in London, has appealed to big pharma companies and suppliers to follow the principle of ‘philanthropic pricing policy’ for the benefit of underprivileged children across the world.
Poonawalla announced that SII has offered GAVI its pentavalent vaccine at $1.75, which was earlier purchased by GAVI at more than $3 per dose. “This is the most affordable vaccine offered by any manufacturer in the world,” Poonawalla said more....

Monday, June 13, 2011      DNA
Serum Institute lowers price of pentavalent vaccine
The Bill and Melinda Gates Foundation has welcomed the initiative of city-based pharmaceutical giant, Serum Institute of India (SII), to lower the price of its pentavalent vaccine for the developing world and for the United Nations Children’s Fund (Unicef).
 more....

Monday, June 13, 2011      Indian Express
Offer vaccines at lower prices: Poonawalla to pharma giants
Dr Cyrus Poonawalla, chief managing director of Serum Institute of India, on Monday urged big pharmaceutical firms to take their lead and offer vaccines at lower prices for saving lives. He was speaking at a pledging conference in London held by the Global Alliance for Vaccines and Immunisation (GAVI). British Prime Minister David Cameron and Bill Gates, co-founder of the Bill and Melinda Gates foundation.  more....

Monday, December  27, 2010
NDTV Profit TV Interview  with Dr. Cyrus & Adar Poonawalla.
View Interview

Wednesday, September 29, 2010      Sakal Times
Dr. Cyrus Poonawalla receives receives US Excellence Award from PAHO & PAHEF
The Pan American Health Organization (PAHO) and the Pan American Health and Education Foundation (PAHEF) have presented Dr Cyrus S Poonawalla, with the Award for “Excellence in Inter-American Public Health”, making him the first Indian to get this prestigious honor in Washington DC, USA. Dr. Poonawalla received this award from Dr. Mirta Roses Periago, director of the Pan American Health Organization (PAHO) for his extraordinary contribution to eliminate rubella and congenital rubella syndrome in America.  more....

Wednesday, September 29, 2010
Dr. Cyrus S. Poonawalla interview at the Pan American Health Organization about Rubella vaccines & Serum Institute of India.
View Interview

Thursday, July 15, 2010      BioSpectrum
Serum Institute launches intra-nasal swine flu vaccine Nasovac in India
Serum Institute of India launched its intra-nasal Swine Flu Vaccine  more....

Friday, August 14, 2009      DNA Pune
Vaccine is Serum Institute's top priority
City-based Serum Institute of India has been told to concentrate on the development of the H1N1 vaccine and put the development of H5N1 (avian flu) vaccine on the back burner by the World Health Organisation (WHO). more....

Wednesday, August 5, 2009      DNA Mumbai
Serum Institute to speed up vaccine production
Serum Institute of India (SII) in Pune is looking forward to an early date for producing a H1N1 vaccine. more....

Monday, August 3 2009
The Forbes India Show, CNBC TV18      TV Interview
View Interview

Friday, July 31, 2009      Sakal Times Pune
Serum Institute preparing vaccine
Serum Institute is working on Influenza A H1N1 virus strain to prepare a injectable vaccine to be ready for animal testing in the next two months. more....